News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
299,809 Results
Type
Article (16796)
Company Profile (53)
Press Release (282953)
Multimedia
Podcasts (10)
Webinars (6)
Section
Business (83889)
Career Advice (1277)
Deals (15604)
Drug Delivery (28)
Drug Development (37482)
Employer Resources (95)
FDA (6492)
Job Trends (6458)
News (143353)
Policy (12287)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1400)
Accelerated approval (14)
Adcomms (8)
Allergies (72)
Alliances (21530)
ALS (88)
Alzheimer's disease (929)
Antibody-drug conjugate (ADC) (163)
Approvals (6726)
Artificial intelligence (339)
Autoimmune disease (80)
Automation (16)
Bankruptcy (123)
Best Places to Work (5698)
BIOSECURE Act (3)
Biosimilars (78)
Biotechnology (44)
Bladder cancer (102)
Brain cancer (40)
Breast cancer (448)
Cancer (2888)
Cardiovascular disease (181)
Career advice (1083)
Career pathing (26)
CAR-T (116)
CDC (5)
Celiac Disease (1)
Cell therapy (330)
Cervical cancer (21)
Clinical research (33000)
Collaboration (887)
Company closure (1)
Compensation (172)
Complete response letters (27)
COVID-19 (1289)
CRISPR (29)
C-suite (379)
Cystic fibrosis (80)
Data (3899)
Decentralized trials (2)
Denatured (4)
Depression (80)
Diabetes (229)
Diagnostics (4060)
Digital health (23)
Diversity (6)
Diversity, equity & inclusion (27)
Drug discovery (148)
Drug pricing (36)
Drug shortages (9)
Duchenne muscular dystrophy (102)
Earnings (42481)
Editorial (18)
Employer branding (14)
Employer resources (89)
Events (40825)
Executive appointments (450)
FDA (8307)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (5)
Frontotemporal dementia (15)
Funding (640)
Gene editing (74)
Generative AI (22)
Gene therapy (244)
GLP-1 (364)
Government (1845)
Grass and pollen (1)
Guidances (288)
Healthcare (8300)
HIV (24)
Huntington's disease (13)
IgA nephropathy (48)
Immunology and inflammation (103)
Immuno-oncology (27)
Indications (54)
Infectious disease (1420)
Inflammatory bowel disease (122)
Inflation Reduction Act (1)
Influenza (71)
Intellectual property (146)
Interviews (225)
IPO (8368)
IRA (8)
Job creations (981)
Job search strategy (895)
JPM (20)
Kidney cancer (10)
Labor market (38)
Layoffs (128)
Leadership (23)
Legal (1960)
Liver cancer (50)
Longevity (5)
Lung cancer (391)
Lymphoma (204)
Machine learning (25)
Management (34)
Manufacturing (311)
MASH (67)
Medical device (5598)
Medtech (5624)
Mergers & acquisitions (7903)
Metabolic disorders (523)
Multiple sclerosis (101)
NASH (5)
Neurodegenerative disease (136)
Neuropsychiatric disorders (39)
Neuroscience (1590)
NextGen: Class of 2026 (2542)
Non-profit (1692)
Now hiring (10)
Obesity (213)
Opinion (150)
Ovarian cancer (114)
Pain (91)
Pancreatic cancer (166)
Parkinson's disease (162)
Partnered (23)
Patents (289)
Patient recruitment (272)
Peanut (17)
People (20753)
Pharmaceutical (15)
Pharmacy benefit managers (4)
Phase 1 (10331)
Phase 2 (14658)
Phase 3 (11116)
Pipeline (3295)
Policy (69)
Postmarket research (1000)
Preclinical (4176)
Press Release (19)
Prostate cancer (134)
Psychedelics (17)
Radiopharmaceuticals (151)
Rare diseases (415)
Real estate (1573)
Recruiting (44)
Regulatory (10665)
Reports (22)
Research institute (1324)
Resumes & cover letters (192)
Rett syndrome (23)
RNA editing (5)
RSV (24)
Schizophrenia (85)
Series A (84)
Series B (76)
Service/supplier (3)
Sickle cell disease (37)
Special edition (13)
Spinal muscular atrophy (71)
Sponsored (23)
Startups (1355)
State (1)
Stomach cancer (6)
Supply chain (37)
Tariffs (17)
The Weekly (6)
Vaccines (373)
Venture capital (27)
Weight loss (101)
Women's health (41)
Worklife (10)
Date
Today (30)
Last 7 days (271)
Last 30 days (1003)
Last 365 days (16072)
2026 (1426)
2025 (16352)
2024 (18848)
2023 (21576)
2022 (27159)
2021 (31011)
2020 (28371)
2019 (20736)
2018 (15287)
2017 (14556)
2016 (12757)
2015 (15237)
2014 (10455)
2013 (7753)
2012 (8183)
2011 (8530)
2010 (7584)
Location
Africa (369)
Alabama (22)
Alaska (3)
Arizona (97)
Arkansas (3)
Asia (17068)
Australia (2896)
California (5861)
Canada (2035)
China (454)
Colorado (301)
Connecticut (320)
Delaware (182)
Europe (39693)
Florida (901)
Georgia (203)
Idaho (68)
Illinois (459)
India (26)
Indiana (227)
Iowa (16)
Japan (246)
Kansas (82)
Kentucky (10)
Louisiana (14)
Maine (64)
Maryland (663)
Massachusetts (4229)
Michigan (196)
Minnesota (314)
Mississippi (1)
Missouri (52)
Montana (11)
Nebraska (12)
Nevada (75)
New Hampshire (42)
New Jersey (1737)
New Mexico (10)
New York (1711)
North Carolina (732)
North Dakota (3)
Northern California (2903)
Ohio (142)
Oklahoma (4)
Oregon (12)
Pennsylvania (1187)
Puerto Rico (11)
Rhode Island (24)
South America (500)
South Carolina (44)
Southern California (2288)
Tennessee (71)
Texas (1087)
United States (21276)
Utah (189)
Virginia (159)
Washington D.C. (46)
Washington State (463)
West Virginia (1)
Wisconsin (42)
299,809 Results for "prisym id".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dymicron Announces First Patient Enrolled in Triadyme-C IDE Clinical Trial
January 16, 2026
·
3 min read
Press Releases
IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance
December 5, 2025
·
3 min read
Press Releases
Affera™ momentum continues as Medtronic announces CE Mark in Europe and U.S. IDE first cases for Sphere-360™ PFA catheter to treat paroxysmal atrial fibrillation
January 26, 2026
·
6 min read
Press Releases
Novocuff Announces IDE Approval for the RETAIN Study
September 17, 2025
·
2 min read
Press Releases
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
December 18, 2025
·
5 min read
Press Releases
Airiver Medical Secures IDE Approval from the FDA for Pivotal Clinical Study of the Airiver Drug Coated Balloon for Patients with Chronic Rhinosinusitis
December 10, 2025
·
2 min read
Press Releases
ViaLase Announces First Patient Treated in IDE Clinical Trial Evaluating Its Femtosecond Laser Trabeculotomy for Open-Angle Glaucoma
December 3, 2025
·
3 min read
Press Releases
Renerva Receives FDA IDE Approval to Commence First-in-Human Study of its Renerva PNM-CAP™ Device for Neuroma Pain
December 4, 2025
·
3 min read
Press Releases
MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
November 6, 2025
·
4 min read
Press Releases
IDEAYA Biosciences Announces IND Submission for IDE574, a Potential First-In-Class KAT6/7 Dual Inhibitor for Breast and Lung Cancers
December 10, 2025
·
4 min read
1 of 29,981
Next
